Cyclopropylamines as LSD1 inhibitors
US10174030B2 · kind B2 · utility
14Cited by
15References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 26, 2017 |
| Grant date | Jan 8, 2019 |
| Priority date | — |
| Expiry date | Apr 26, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to cyclopropylamine derivatives which are LSD1 inhibitors useful in the treatment of diseases such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.